Skip to content

Clinical trials

Phase 1 Blast Crisis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blast Crisis Phase: Phase 1 Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20024
20036
200412
20059
20067
20074
20084
20096
20103
20111
20121
20153
20162
20172
20182
20191
20202
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Terminated17
Recruiting3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)31
M.D. Anderson Cancer Center9
Memorial Sloan Kettering Cancer Center5
Northwestern University4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Case Comprehensive Cancer Center3
Vion Pharmaceuticals3
Virginia Commonwealth University3
Barbara Ann Karmanos Cancer Institute2
Fred Hutchinson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blast Crisis108
Precursor Cell Lymphoblastic Leukemia-Lymphoma92
Leukemia, Myeloid, Acute87
Leukemia56
Leukemia, Myeloid, Accelerated Phase53
Leukemia, Lymphocytic, Chronic, B-Cell46
Leukemia, Myeloid, Chronic-Phase44
Leukemia, Myelomonocytic, Chronic43
Myelodysplastic Syndromes40
Congenital Abnormalities38

Trials

Showing 76 to 100 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.